Ovarian aging and infertility;Procesy starzenia się komórki jajowej a niepłodność

Ginekologia Polska

Volumn 84, Issue 4, 2013, Pages 298-304

  Szafarowska, Monika ^a   Jerzak, Małgorzata ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Apoptosis; Infertility; Ovary aging; Oxidative stress; Telomeres; VEGF

Indexed keywords

MITOCHONDRIAL DNA; MUELLERIAN INHIBITING FACTOR; TELOMERASE;

AGING; FEMALE; FEMALE INFERTILITY; HUMAN; MENOPAUSE; METABOLISM; OOCYTE; OVARY; OVARY FOLLICLE; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

AGING; ANTI-MULLERIAN HORMONE; DNA, MITOCHONDRIAL; FEMALE; HUMANS; INFERTILITY, FEMALE; MENOPAUSE; OOCYTES; OVARIAN FOLLICLE; OVARY; OXIDATIVE STRESS; TELOMERASE;

MLCS; MLOWN;

EID: 84879203498     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: 10.17772/gp/1580     Document Type: Article

References (98)

1. Speroff L, Fritz M. Nieplodnośćzeńska. W: Kliniczna endokrynologia ginekologiczna i nieplodność. Red. Jakimiuk A, Czajkowski K. Warszawa: MediPage, 2007, 1179.
2. Faddy M, Gosden R. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod. 1996, 11, 1484-1486.
3. Tilly J. Commuting the death sentence: how oocytes strive to survive. Nat Rev Mol Cell Biol. 2001, 2, 838-848.
4. Tatone C, Carbone M, Gallo R, [et al.]. Age-associated changes in mouse oocytes during postovulatory in vitro culture: possible role for meiotic kinases and survival factor BCL2. Biol Reprod. 2006, 74, 395-402.
5. Tatone C, Amicarelli F, Carbone M, [et al.]. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update. 2008, 14, 131-42.
6. Velde E, Pearson P. The variability of female reproductive ageing. Hum Reprod Update. 2002, 8, 141-154.
7. Sauer M, Paulson R, Lobo R. A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med. 1990, 323, 1157-1160.
8. Van Blerkom J, Sinclair J, Davis P. Mitochondrial transfer between oocytes: potential applications of mitochondrial donation and the issue of heteroplasmy. Hum Reprod. 1998, 13, 2857-2868.
9. Zhang X, Wu XQ, Lu S, [et al.]. Deficit of mitochondria-derived ATP during oxidative stress impairs mouse MII oocyte spindles. Cell Res. 2006, 16, 841-850.
10. Yi YC, Chen MJ, Ho JY, [et al.]. Mitochondria transfer can enhance the murine embryo development. J Assist Reprod Genet. 2007, 24, 445-449.
11. Perez G, Jurisicova A, Matikainen T, [et al.]. A central role for ceramide in the age-related acceleration of apoptosis in the female germline. FASEB J. 2005, 19, 860-862.
12. Tatone C, Carbone M, Falone S, [et al.]. Age-dependent changes in the expression of superoxide dismutases and catalase are associated with ultrastructural modifications in human granulosa cells. Mol Hum Reprod. 2006, 12, 655-660.
13. Battaglia D, Goodwin P, Klein N, Sovles M. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod. 1996, 11, 2217-2222.
14. Liu L, Keefe D. Ageing-associated aberration in meiosis of oocytes from senescenceaccelerated mice. Hum Reprod. 2002, 17, 2678-2685.
15. Tarín J, Pérez-Albalá S, Cano A. Cellular and morphological traits of oocytes retrieved from aging mice after exogenous ovarian stimulation. Biol Reprod. 2001, 65, 141-150.
16. Dumollard R, Duchen M, Carroll J. The role of mitochondrial function in the oocyte and embryo. Curr Top Dev Biol. 2007, 77, 21-49.
17. Takeuchi T, Neri Q, Katagiri Y, [et al.]. Effect of treating induced mitochondrial damage on embryonic development and epigenesis. Biol Reprod. 2005, 72, 584-592.
18. Redmer A, Reynolds L. Angiogenesis in the ovary. Rev Reprod. 1996, 1, 182-192.
19. Costello M, Shrestha S, Sjoblom P, [et al.]. Power doppler ultrasound assessment of the relationship between age and ovarian perifollicular blood flow in women undergoing in vitro fertilization treatment. J Assist Reprod Genet. 2006, 23, 359-365.
20. Kok H, van Asselt K, van der Schouw Y, [et al.]. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol. 2006, 47, 1976-1983.
21. Chandel N, Budinger G. The cellular basis for diverse responses to oxygen. Free Radic Biol Med. 2007, 42,165-174.
22. Klein N, Battaglia D, Woodruff T, [et al.]. Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. J Clin Endocrinol Metab. 2000, 85, 4520-4525.
23. Artini P, Monti M, Cristello F, [et al.]. Vascular endothelial growth factor in females of reproductive age. Gynecol Endocrinol. 2003, 17, 477-492.
24. Sohal R. Role of oxidative stress and protein oxidation in the aging process. Free Radic Biol Med. 2002, 33, 37-44.
25. Kulbacka J, Saczko J, Chwilkowska A. Oxidative stress in cells damage processes. Pol Merkur Lekarski. 2009, 27, 44-47.
26. Sheu S, Nauduri D, Anders M. Targeting antioxidants to mitochondria: A new therapeutic direction. Biochim Biophys Acta. 2006, 1762, 256-265.
27. Galecka E, Mrowicka M, Malinowska K. [et al.]. Wolne rodniki tlenu i azotu w fizjologii. Pol Merkur Lek. 2008, 24, 446-448.
28. Agarwal A, Gupta S, Sharma R. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005, 3, 28.
29. Bailey M, Landar A, Darley-Usmar V. Mitochondrial proteomics in free radical research. Free Radic Biol Med. 2005, 38,175-188.
30. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol. 2007, 47, 143-183.
31. Das S, Chattopadhyay R, Ghosh S, [et al.]. Reactive oxygen species level in follicular fluid-- embryo quality marker in IVF?. Hum Reprod. 2006, 21, 2403-2407.
32. Wiener-Megnazi Z, Vardi L, Lissak A, [et al.]. Oxidative stress indices in follicular fluid as measured by the thermochemiluminescence assay correlate with outcome parameters in vitro fertilization. Fertil Steril. 2004, 82, Suppl 3,1171-1176.
33. Carbone M, Tatone C, Delle Monache S, [et al.]. Antioxidant enzymatic defences in human follicular fluid: characterization and age-dependent changes. Mol Hum Reprod. 2003, 9, 639- 643.
34. Dalle-Donne I, Rossi R, Giustarini D, [et al.]. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003, 329, 23-38.
35. de Magalhães J, Curado J, Church G. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009, 25, 875-881.
36. Masoro E. Overview of caloric restriction and ageing. Mech Ageing Dev. 2005, 126, 913-922.
37. Swindell W. Genes and gene expression modules associated with caloric restriction and aging in the laboratory mouse. BMC Genomics. 2009, 10, 585.
38. Hong S, Heo H, Kim D, [et al.]. Revealing system-level correlations between aging and calorie restriction using a mouse transcriptome. Age (Dordr). 2010, 32, 15-30.
39. Sharma P, Mittal N, Deswal S, Roy N. Calorie restriction up-regulates iron and copper transport genes in Saccharomyces cerevisiae. Mol Biosyst. 2011, 7, 394-402.
40. Blackburn E. Telomeres and telomerase: their mechanism of action and the effects of altering their function. Febbs Lett. 2005, 579, 859-863.
41. Verdun R, Karlseder J. Replication and protection of telomeres. Nature. 2007, 447, 924-931.
42. Kurz D, Decary S, Hong Y, [et al.]. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci. 2004, 117, 2417- 2426.
43. Passos J, von Zglinicki T. Mitochondria, telomeres and cell senescence. Exp Gerontol. 2005, 40, 466-72.
44. Keefe D, Franco S, Liu L, [et al.]. Telomere length predicts embryo fragmentation after in vitro fertilization in women--toward a telomere theory of reproductive aging in women. Am J Obstet Gynecol. 2005, 192, 1256-1260.
45. Keefe D, Liu L, Marquard K. Telomeres and aging-related meiotic dysfunction in women. Cell Mol Life Sci. 2007, 64, 139-143.
46. Hande M, Samper E, Lansdorp P, [et al.]. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol. 1999, 144,589-601.
47. Battaglia D, Goodwin P, Klein N, Sovles M. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod. 1996, 11, 2217-2222.
48. Keefe D. Telomeres and meiosis in health and disease. Cell Mol Life Sci. 2007, 64, 115-116.
49. Baynes J. The role of AGEs in aging: causation or correlation. Exp Gerontol. 2001, 36, 1527- 1537.
50. Yin M, Yin H, Lee C, [et al.]. Protein glycation: creation of catalytic sites for free radical generation. Ann N Y Acad Sci. 2001, 928, 48-53.
51. Schmidt A, Yan S, Yan S, Stern D. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta. 2000, 1498, 99-111.
52. Jinno M, Takeuchi M, Watanabe A, [et al.]. Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology. Hum Reprod. 2011, 26, 604-610.
53. Visser J, de Jong F, Laven J, Themmen M. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006, 131, 1-9.
54. Karkanaki A, Vosnakis Ch, Panidis D. The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology. Hormones. 2011, 10, 95-103.
55. Skałba P, Cygal A, Dabkowska-Huc A. Wplyw hormonu anty-Müllerowskiego (AMH) na folikulogeneze{ogonek}. Ginekol Pol. 2008, 79, 137-140.
56. Hagen C, Aksglaede L, Sorensen K, [et al.]. Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum Reprod. 2012, 27, 861-866.
57. Kevenaar M, Meerasahib M, Kramer P, [et al.]. Serum anti-Müllerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology. 2006, 147, 3228-3234.
58. de Vet A, Laven J, de Jong F, [et al.]. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002, 77, 357-362.
59. Hampl R, Šnajderová M, Mardeši T. Antimüllerian hormone (AMH) not only a marker for prediction of ovarian reserve. Physiol Res. 2011, 60, 217-223.
60. Sowers M, Eyvazzadeh A, McConnell D, [et al.]. Anti-müllerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008, 93, 3478-3483.
61. Younis J. Ovarian aging: latest thoughts on assessment and management. Curr Opin Obstet Gynecol. 2011, 23, 427-434.
62. Loh J, Maheshwari A. Anti-Müllerian hormone-is it a crystal ball for predicting ovarian ageing?. Hum Reprod. 2011, 26, 2925-2932.
63. Carvalho B, Gomes Sobrinho D, Vieira A, [et al.]. Ovarian Reserve Assessment for Infertility Investigation. Obstet Gynecol. 2012, 576, 385.
64. Nelson S, Anderson R, Broekmans F, [et al.]. Anti-Müllerian hormone: clairvoyance or crystal clear? Hum Reprod. 2012, 27, 631-636.
65. Nelson S, Lawlor D. Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles. PLoS Med. 2011, 8,e1000386.
66. Hirokawa W, Iwase A, Gotto M, [et al.]. The postoperative decline in serum anti-Müllerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod. 2011, 26, 904-910.
67. Wikarek T, Olszanecka-Glinianowicz M, Chudek J, [et al.]. Hormon anty-Müllerowski a zaburzenia płodności u otylych kobiet i kobiet z zespolem policystycznych jajników. Ginekol Pol. 2011, 82, 205-209.
68. Weghofer A, Kim A, Barad D, Gleicher N. Follicle stimulating hormone and anti-müllerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort study. PLoS One. 2012, 7, 34290.
69. Bancsi L, Broekmans F, Mol B, [et al.]. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril. 2003, 79,1091-1100.
70. van der Steeg J, Steures P, Eijkemans M, [et al.]. Predictive value and clinical impact of basal follicle stimulating hormone in subfertile, ovulatory women. J Clin Endocrinol Metab. 2007, 92, 2163-2168.
71. Andersen A, Witjes H, Gordon K, [et al.]. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod. 2011, 26, 3413-3423.
72. Erdem M, Erdem A, Gursoy R, Biberogh K. Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF. J Assist Reprod Genet. 2004, 21, 37-45.
73. Eldar-Geva T, Ben-Chetrit A, Spitz I, [et al.]. Dynamic assays of inhibin B, anti-Müllerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Human Reprod. 2005, 20, 3178-3183.
74. Ashrafi M, Madani T, Seirafi Tehranian A, Kalekzadeh F. Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF. Int J Gyneacol Obstet. 2005, 91, 53-57.
75. Vladimirov I, Tacheva D, Kalinov K, [et al.]. Prognostic value of some ovarian reserve tests in poor responders. Arch Gynecol Obstet. 2005, 272, 74-9.
76. Laven J, Fauser B. What role of estrogens in ovarian stimulation. Maturitas. 2006, 20, 54, 356- 362.
77. Bancsi L, Broekmans F, Eijkemans M, [et al.]. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002, 77, 328-336.
78. Miao M, Huang H. Dynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatment. J Zhejiang Univ Sci B. 2009, 10, 35-45.
79. Costello M, Hughes G, Garrett D, [et al.]. Prognostic value of baseline serum oestradiol in controlled ovarian hyperstimulation of women with unexplained infertility. Aust N Z J Obstet Gynaecol. 2001, 41, 69-74.
80. Anifandis G, Koutselini E, Louridas K, [et al.]. Estradiol and leptin as conditional prognostic IVF markers. Reproduction. 2005, 129, 531-534.
81. Kondapalli L, Molinaro T, Sammel M, Dokras A. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum Reprod. 2012, 27, 2690-2697.
82. Hazout A, Bouchard P, Seifer D, [et al.]. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004, 82, 1323-1329.
83. Sharara F. Value of mid-luteal oestradiol level: prognostic implications for IVF. Hum Reprod. 2001, 16, 2476.
84. Lee TH, Liu CH, Huang CC, [et al.]. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008, 23, 160-167.
85. Tinkanen H, Blauer M, Laippala P, [et al.]. Correlation between serum inhibin B and other indicators of the ovarian function. Eur J Obstet Gynecol Reprod Biol. 94, 109-113.
86. Peñarrubia J.Peralta S, Fábregues F, [et al]. Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression. Fertil Steril. 2010, 94, 2590-2595.
87. Broekmans F, Kwee J, Hendriks D. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006, 12, 685-718.
88. Chen Y, Yu Q, Zhang YW, [et al.]. Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle. Zhonghua Fu Chan Ke Za Zhi. 2006, 41, 368-371.
89. Urbancsek J, Hauzman E, Murber A, [et al.]. Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles. Gynecol Endocrinol. 2005, 21, 38-44.
90. Miao M, Huang H. Dynamic assay of serum inhibin B and estradiol concentrations obtained after gonadotrophin therapy as predictors of ovarian response in vitro fertilization cycle. Zhonghua Fu Chan Ke Za Zhi. 2006, 41, 114-117.
91. Wunder D, Guibourdenche J, Birkhäuser M, [et al.]Bersinger N. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2008, 90, 2203-2210.
92. Scheffer J, Lozano D, Frydman R, [et al.]. Relationship of serum anti-Müllerian hormone, inhibin B, estradiol and FSH on day 3 with ovarian follicular status. Rev Bras Ginecol Obstet. 2007, 29, 186-191.
93. Bonilla-Musoles F, Castillo J, Caballero O, [et al.]. Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure. Clin Exp Obstet Gynecol. 2012, 39, 13-18.
94. Elgindy E, El-Haieg D, El-Sebaey A. Anti-Mullerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Fertil Steril. 2008, 89, 1670-1676.
95. Ben-Haroush A, Farhi J, Zahalka Y, [et al.]. Small antral follicle count (2-5 mm) and ovarian volume for prediction of pregnancy in in vitro fertilization cycles. Gynecol Endocrinol. 2011, 27,748-752.
96. Maseelall P, Hernandez-Rey A, Oh C, [et al.]. Antral follicle count is a significant predictor of live birth in in vitro fertilization cycles. Fertil Steril. 2009, 91, 1595-1597.
97. Gibreel A, Maheshwari A, Bhattacharya S, [et al.]. Ultrasound tests of ovarian reserve; A systematic review of accuracy in predicting fertility outcomes. Hum Fert. 2009, 12, 95-106.
98. Verhagen T, Hendriks DJ, Bancsi L, [et al.]. The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis. Hum Reprod Update. 2008, 14, 95-100.